Jaffetilchin Investment Partners LLC increased its stake in Aetna Inc. (NYSE:AET) by 11.1% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 4,281 shares of the company’s stock after buying an additional 428 shares during the period. Jaffetilchin Investment Partners LLC’s holdings in Aetna were worth $650,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. FTB Advisors Inc. increased its stake in Aetna by 11.0% in the first quarter. FTB Advisors Inc. now owns 977 shares of the company’s stock worth $125,000 after buying an additional 97 shares during the period. Signature Estate & Investment Advisors LLC acquired a new stake in Aetna during the first quarter worth $133,000. Liberty Capital Management Inc. increased its stake in Aetna by 206.9% in the second quarter. Liberty Capital Management Inc. now owns 933 shares of the company’s stock worth $144,000 after buying an additional 629 shares during the period. Guardian Life Insurance Co. of America increased its stake in Aetna by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 1,353 shares of the company’s stock worth $173,000 after buying an additional 9 shares during the period. Finally, Tompkins Financial Corp acquired a new stake in Aetna during the first quarter worth $187,000. Institutional investors and hedge funds own 91.69% of the company’s stock.

Shares of Aetna Inc. (NYSE:AET) opened at 155.76 on Wednesday. Aetna Inc. has a 52-week low of $104.59 and a 52-week high of $161.69. The stock has a market cap of $51.73 billion, a PE ratio of 34.57 and a beta of 0.54. The company’s 50-day moving average is $154.49 and its 200-day moving average is $139.88.

Aetna (NYSE:AET) last issued its quarterly earnings results on Thursday, August 3rd. The company reported $3.42 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.34 by $1.08. Aetna had a net margin of 2.52% and a return on equity of 20.52%. The company had revenue of $15.52 billion during the quarter, compared to the consensus estimate of $15.34 billion. During the same quarter in the previous year, the firm earned $2.21 earnings per share. The firm’s quarterly revenue was down 2.7% on a year-over-year basis. Equities analysts anticipate that Aetna Inc. will post $9.52 EPS for the current year.

The company also recently declared a quarterly dividend, which was paid on Friday, July 28th. Investors of record on Thursday, July 13th were paid a $0.50 dividend. The ex-dividend date of this dividend was Tuesday, July 11th. This represents a $2.00 dividend on an annualized basis and a yield of 1.28%. Aetna’s dividend payout ratio is currently 43.67%.

WARNING: “Aetna Inc. (AET) Shares Bought by Jaffetilchin Investment Partners LLC” was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this article on another domain, it was illegally copied and republished in violation of U.S. and international trademark and copyright law. The legal version of this article can be viewed at https://www.thecerbatgem.com/2017/08/16/aetna-inc-aet-shares-bought-by-jaffetilchin-investment-partners-llc.html.

AET has been the topic of several analyst reports. Royal Bank Of Canada reiterated a “buy” rating and set a $145.00 price target on shares of Aetna in a report on Monday, April 24th. Bank of America Corporation reiterated a “buy” rating and set a $168.00 price target (up from $160.00) on shares of Aetna in a report on Wednesday, May 17th. Morgan Stanley initiated coverage on shares of Aetna in a report on Tuesday, June 6th. They set an “overweight” rating and a $162.00 price target on the stock. Zacks Investment Research upgraded shares of Aetna from a “hold” rating to a “buy” rating and set a $170.00 price target on the stock in a report on Tuesday, July 4th. Finally, Jefferies Group LLC reiterated a “hold” rating and set a $163.00 price target (up from $157.00) on shares of Aetna in a report on Friday, August 4th. Eight equities research analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $157.09.

In related news, EVP Margaret M. Mccarthy sold 27,028 shares of Aetna stock in a transaction that occurred on Wednesday, June 7th. The shares were sold at an average price of $149.23, for a total value of $4,033,388.44. Following the completion of the transaction, the executive vice president now owns 33,563 shares in the company, valued at $5,008,606.49. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.14% of the stock is owned by insiders.

About Aetna

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Stock Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related stocks with our FREE daily email newsletter.